Transplantation experiments using immunocomprimised mice, showed that as few as 100 human breast cancer cells with the cell surface markers CD44+CD24−/low were tumorigenic and could be serially passaged to generate new tumours [13]. The gene discussed is CD44; the disease is breast carcinoma.